In accordance, anti-CCL5 antibody decreased tumor growth and the invasive property induced by miR-CAF co-injected in an orthotopic ovarian cancer mouse model, confirming CCL5 is a tumor-promoting factor [139]. This evidence concerns the gene CCL5 and ovarian cancer.